Mendel Biotechnology, Inc.
Arriva Pharmaceuticals, Inc.
Venture Law Group
Fried, Frank, Harris Shriver & Jacobson LLP
Greg has spent more than 20 years advising biotech companies on corporate and complex transactional matters, including structuring and negotiating strategic R&D collaborations, interactions with academic institutions, board governance and venture and non-dilutive financings. His mix of business and legal in-house experience enables him to provide pragmatic, business-focused solutions to intricate challenges faced by life sciences companies.
Representative clients include Aduro Biotech, Aimmune Therapeutics, Allogene Therapeutics, The Bluefield Project to Cure FTD, Epalex Corporation, IDEAYA Biosciences and Pliant Therapeutics.
Mendel Biotechnology, Inc.
CEO
Venture Law Group and Heller Ehrman
Partner